| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |